Manx Parliament Expected to Approve 2023 E-Cigarette Product Act

Regulations by 2FIRSTS.ai

Mar.29.2024

Manx Parliament Expected to Approve 2023 E-Cigarette Product Act

The Isle of Man's "2023 e-cigarette Products Act" expected to gain royal approval at the next Tynwald meeting on April 16.

According to a report from iomtoday on March 29th, the "2023 E-Cigarette Products Bill" in the Isle of Man is expected to receive royal approval at the next Tynwald Court meeting scheduled for April 16th (Tuesday).

If the bill is passed, it will be illegal for individuals under the age of 18 to purchase e-cigarette products in the Isle of Man starting from mid-April.

Last June, the lower house of parliament passed the relevant legislation, and it received final approval from the legislative committee in October.

Kate Lord-Brennan, Minister of the Isle of Man Cabinet Office, announced during a session of the House of Keys on Tuesday, March 26th, that the "2023 e-cigarette Products Act" was passed by all departments on December 19, 2023.

The Public Prosecution Service has requested a very short turnaround time during the Christmas period to update the legislation based on amendments from the Legislative Council. After completing these updates, the legislation was sent to the Department of Justice on January 11th, and the department has indicated that the legislation is scheduled to receive royal approval in April as planned.

References:

[1] Vaping Bill expected to gain royal assent during April's Tynwald sitting

Also Read:

[1] British Association Warns of Illegal Trade Growth Post E-Cigarette Ban

#Europe #Legislation #E-cigarettes #Open system e-cigarettes #Product #Isle of Man

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

Canadian Media Investigation: BAT’s Nicotine Pouch ZONNIC Sparks Ongoing Controversy as Regulatory Gaps in Canada Come Under Scrutiny

Canadian outlet Rebel News released a long-form video report examining Canada’s regulatory framework for nicotine pouches, market dynamics, and the approval process of ZONNIC, a product of BAT subsidiary Imperial Tobacco Canada. The report highlights issues involving youth access, regulatory gaps, black-market activity, retailer feedback, and company responses. This article summarizes key points based on the video.

Dec.02 by 2FIRSTS.ai

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

UK Peer Seeks to Weaken “Generational Smoking Ban” – Report Reveals Discussions with BAT Executive Relative

Lord Strathcarron, a member of the UK House of Lords, has admitted to discussing the government’s Tobacco and Vapes Bill with a relative who holds a senior role at British American Tobacco (BAT). He is advocating amendments to scrap the bill’s core “generational smoking ban” provision, raising questions of potential conflict of interest.

Oct.27

New Zealand Health Ministry launches e-cigarette and nicotine pod procurement project for smoking cessation services

Health NZ launches e-cigarette and nicotine pod procurement project for 29 government-funded smoking cessation services, following WHO guidelines.